Non-interventional Study of Pomalidomide (Imnovid) in Combination With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 Aug 2019
Price : $35 *
At a glance
- Drugs Pomalidomide (Primary) ; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms Poseidon
- 31 Aug 2018 Biomarkers information updated
- 26 Apr 2017 Planned End Date changed from 1 Sep 2020 to 1 Mar 2021.
- 26 Apr 2017 Planned primary completion date changed from 1 Jul 2020 to 1 Mar 2021.